<DOC>
	<DOC>NCT01227863</DOC>
	<brief_summary>The primary objective of this study is to evaluate, through clinical parameters, the effectiveness of your medicine topic Maxinom 速 (dexamethasone, neomycin and polymyxin B - Union Chemicals), comparing it to the topical medication Maxitrol 速 (dexamethasone, neomycin and polymyxin B - Alcon ) by the percentage of improvement (sustained response rate) at the end of treatment, among the products studied.</brief_summary>
	<brief_title>Efficacy Maxinom速 And Maxitrol速 in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis</brief_title>
	<detailed_description>1. Evaluation of isolated signs and symptoms during treatment, with a record of individual scores for each parameter and observation 2. Statistical comparison of drug safety, by recording qualitative and quantitative parameters related to adverse effects occurring during treatment.</detailed_description>
	<mesh_term>Signs and Symptoms</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Bacterial</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Fluprednisolone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Neomycin</mesh_term>
	<mesh_term>Polymyxin B</mesh_term>
	<mesh_term>Polymyxins</mesh_term>
	<mesh_term>Dexamethasone, neomycin, polymyxin B drug combination</mesh_term>
	<mesh_term>Bacitracin</mesh_term>
	<mesh_term>Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination</mesh_term>
	<criteria>Patients who agree with all study procedures and sign, by his own free will, IC; Adult patients, regardless of gender, ethnicity or social status, with good mental health; Patients who present at screening visit, picture of acute bacterial conjunctivitis diagnosed clinically. Patients with clinical diagnosis or suspicion of conjunctivitis due to any process that is not due to bacterial infection, such as infections by fungi, protozoa, viruses and allergic conjunctivitis; Patients with known hypersensitivity to any component of the formulas of the study drugs; Patients with a history or clinical diagnosis of other lesions that may affect the outcome, such as glaucoma, corneal ulcer or scars; Concomitant use of ocular medication other than the study; Pregnant or lactating women; Being or having been treated for any type of conjunctivitis within 15 days and have finished treatment or less than 07 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>SIGNS AND SYMPTOMS OF ACUTE BACTERIAL CONJUNCTIVITIS</keyword>
</DOC>